Scott Cramer
Concepts (430)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Prostatic Neoplasms | 38 | 2022 | 1016 | 4.050 |
Why?
| MAP Kinase Kinase Kinases | 8 | 2021 | 71 | 2.430 |
Why?
| Prostate | 11 | 2014 | 180 | 1.910 |
Why?
| Receptors, Androgen | 8 | 2021 | 147 | 1.220 |
Why?
| DNA Helicases | 4 | 2021 | 149 | 1.190 |
Why?
| Prostate-Specific Antigen | 9 | 2013 | 162 | 1.020 |
Why?
| Hyperoxaluria, Primary | 5 | 2009 | 14 | 0.950 |
Why?
| Epithelial Cells | 10 | 2016 | 1065 | 0.910 |
Why?
| Calcitriol | 6 | 2011 | 55 | 0.900 |
Why?
| Vitamin D | 4 | 2013 | 384 | 0.890 |
Why?
| DNA-Binding Proteins | 5 | 2021 | 1443 | 0.840 |
Why?
| Alcohol Oxidoreductases | 7 | 2011 | 60 | 0.820 |
Why?
| Interleukin-1alpha | 2 | 2013 | 56 | 0.780 |
Why?
| Stromal Cells | 2 | 2014 | 107 | 0.660 |
Why?
| RNA Interference | 2 | 2021 | 448 | 0.650 |
Why?
| Homologous Recombination | 1 | 2019 | 23 | 0.640 |
Why?
| Androgens | 4 | 2021 | 177 | 0.600 |
Why?
| Stem Cells | 3 | 2011 | 577 | 0.540 |
Why?
| DNA Damage | 1 | 2019 | 384 | 0.540 |
Why?
| Cell Line, Tumor | 17 | 2021 | 3215 | 0.530 |
Why?
| Receptors, Calcitriol | 5 | 2015 | 54 | 0.520 |
Why?
| Cell Division | 9 | 2011 | 797 | 0.500 |
Why?
| Tumor Suppressor Proteins | 2 | 2012 | 317 | 0.490 |
Why?
| Epoxy Compounds | 2 | 2015 | 32 | 0.490 |
Why?
| Genomic Instability | 1 | 2015 | 48 | 0.480 |
Why?
| Carnitine O-Palmitoyltransferase | 2 | 2015 | 45 | 0.480 |
Why?
| Autophagy | 5 | 2020 | 268 | 0.480 |
Why?
| Anticarcinogenic Agents | 2 | 2014 | 77 | 0.450 |
Why?
| Lactones | 1 | 2014 | 58 | 0.440 |
Why?
| Antineoplastic Combined Chemotherapy Protocols | 2 | 2014 | 1565 | 0.430 |
Why?
| Breast | 2 | 2014 | 153 | 0.430 |
Why?
| Genistein | 2 | 2004 | 14 | 0.430 |
Why?
| Signal Transduction | 7 | 2022 | 4925 | 0.420 |
Why?
| Cell Proliferation | 9 | 2021 | 2391 | 0.410 |
Why?
| Enzyme Inhibitors | 3 | 2014 | 827 | 0.400 |
Why?
| Nuclear Proteins | 2 | 2015 | 663 | 0.400 |
Why?
| Cell Cycle | 4 | 2021 | 592 | 0.390 |
Why?
| Repressor Proteins | 1 | 2015 | 406 | 0.390 |
Why?
| Mice | 25 | 2022 | 16937 | 0.390 |
Why?
| Male | 51 | 2022 | 63682 | 0.390 |
Why?
| Animals | 34 | 2022 | 35361 | 0.380 |
Why?
| Cells, Cultured | 13 | 2015 | 4083 | 0.380 |
Why?
| Intermediate Filament Proteins | 1 | 2011 | 57 | 0.360 |
Why?
| Adult Stem Cells | 1 | 2011 | 39 | 0.360 |
Why?
| Chromones | 1 | 2010 | 45 | 0.350 |
Why?
| Polymorphism, Single Nucleotide | 8 | 2013 | 2073 | 0.350 |
Why?
| Mice, Knockout | 8 | 2015 | 2871 | 0.350 |
Why?
| Neoplastic Stem Cells | 2 | 2011 | 380 | 0.340 |
Why?
| Necrosis | 4 | 2020 | 232 | 0.340 |
Why?
| Morpholines | 1 | 2010 | 122 | 0.330 |
Why?
| Proto-Oncogene Proteins c-akt | 3 | 2011 | 431 | 0.330 |
Why?
| Nerve Tissue Proteins | 2 | 2011 | 570 | 0.330 |
Why?
| Gene Deletion | 3 | 2011 | 379 | 0.300 |
Why?
| Pregnancy, Animal | 3 | 1992 | 53 | 0.290 |
Why?
| Neoplasm Invasiveness | 4 | 2015 | 485 | 0.290 |
Why?
| Cell Differentiation | 4 | 2014 | 1902 | 0.290 |
Why?
| Carcinoma, Pancreatic Ductal | 1 | 2011 | 270 | 0.290 |
Why?
| Humans | 59 | 2022 | 129652 | 0.290 |
Why?
| Mutation, Missense | 3 | 2009 | 317 | 0.280 |
Why?
| Gene Expression Regulation, Neoplastic | 4 | 2021 | 1356 | 0.270 |
Why?
| Hyperoxaluria | 2 | 2011 | 3 | 0.260 |
Why?
| Clinical Enzyme Tests | 1 | 2006 | 10 | 0.260 |
Why?
| Promoter Regions, Genetic | 4 | 2009 | 1207 | 0.260 |
Why?
| Spectrophotometry | 1 | 2006 | 58 | 0.260 |
Why?
| Prostatic Hyperplasia | 2 | 2004 | 42 | 0.260 |
Why?
| Calcifediol | 3 | 2015 | 31 | 0.250 |
Why?
| Gene Expression Regulation | 6 | 2011 | 2548 | 0.250 |
Why?
| Cell Lineage | 1 | 2007 | 333 | 0.250 |
Why?
| PTEN Phosphohydrolase | 5 | 2019 | 161 | 0.250 |
Why?
| Pancreatic Neoplasms | 2 | 2011 | 882 | 0.240 |
Why?
| Biomarkers, Tumor | 4 | 2019 | 1181 | 0.230 |
Why?
| Genotype | 7 | 2008 | 1839 | 0.230 |
Why?
| Cyclins | 1 | 2004 | 89 | 0.220 |
Why?
| Allelic Imbalance | 1 | 2003 | 8 | 0.220 |
Why?
| Endocrinology | 1 | 2004 | 75 | 0.210 |
Why?
| Fibroblasts | 2 | 2014 | 948 | 0.210 |
Why?
| Proteins | 4 | 1997 | 942 | 0.210 |
Why?
| Cell Cycle Proteins | 3 | 2010 | 586 | 0.210 |
Why?
| Specimen Handling | 1 | 2004 | 164 | 0.210 |
Why?
| Leukocytes, Mononuclear | 1 | 2006 | 545 | 0.210 |
Why?
| Polymorphism, Genetic | 2 | 2003 | 640 | 0.200 |
Why?
| Tumor Cells, Cultured | 8 | 2015 | 940 | 0.200 |
Why?
| Receptors, Somatotropin | 2 | 1992 | 8 | 0.200 |
Why?
| Cell Communication | 1 | 2004 | 301 | 0.200 |
Why?
| Apoptosis | 6 | 2016 | 2503 | 0.200 |
Why?
| Linkage Disequilibrium | 1 | 2003 | 257 | 0.200 |
Why?
| Antineoplastic Agents | 2 | 2004 | 2061 | 0.190 |
Why?
| Parathyroid Hormone | 3 | 1997 | 106 | 0.190 |
Why?
| Drug Synergism | 3 | 2010 | 371 | 0.180 |
Why?
| Phenylthiohydantoin | 1 | 2021 | 44 | 0.180 |
Why?
| Neoplasm Recurrence, Local | 2 | 2021 | 964 | 0.180 |
Why?
| Logistic Models | 2 | 2021 | 1988 | 0.180 |
Why?
| 25-Hydroxyvitamin D3 1-alpha-Hydroxylase | 2 | 2015 | 18 | 0.170 |
Why?
| Mutation | 3 | 2007 | 3717 | 0.170 |
Why?
| Prostatectomy | 2 | 2013 | 106 | 0.170 |
Why?
| Neoplasms | 2 | 2014 | 2470 | 0.170 |
Why?
| Benzamides | 1 | 2021 | 207 | 0.170 |
Why?
| Nitriles | 1 | 2021 | 172 | 0.170 |
Why?
| Pyroptosis | 1 | 2020 | 3 | 0.170 |
Why?
| Cell Line | 7 | 2012 | 2781 | 0.170 |
Why?
| Carrier Proteins | 3 | 1992 | 743 | 0.170 |
Why?
| Colony-Forming Units Assay | 2 | 2011 | 90 | 0.160 |
Why?
| Immunoblotting | 3 | 2010 | 305 | 0.160 |
Why?
| Cellular Senescence | 2 | 2011 | 181 | 0.160 |
Why?
| Fluorescent Antibody Technique | 2 | 2013 | 376 | 0.160 |
Why?
| Molecular Sequence Data | 6 | 2009 | 2832 | 0.150 |
Why?
| Polymerase Chain Reaction | 6 | 2009 | 1038 | 0.150 |
Why?
| Point Mutation | 1 | 1999 | 225 | 0.150 |
Why?
| ADP-ribosyl Cyclase 1 | 1 | 2018 | 37 | 0.150 |
Why?
| Osteoblasts | 2 | 1996 | 124 | 0.150 |
Why?
| Mice, Nude | 3 | 2015 | 683 | 0.150 |
Why?
| Genetic Markers | 2 | 2013 | 338 | 0.150 |
Why?
| NAD | 1 | 2018 | 75 | 0.140 |
Why?
| Drug Resistance, Neoplasm | 2 | 2021 | 759 | 0.140 |
Why?
| RNA, Small Interfering | 3 | 2011 | 587 | 0.140 |
Why?
| Meningeal Neoplasms | 1 | 2019 | 93 | 0.140 |
Why?
| Regeneration | 2 | 2011 | 180 | 0.140 |
Why?
| Transfection | 5 | 2018 | 911 | 0.140 |
Why?
| Gene Expression | 5 | 2018 | 1472 | 0.140 |
Why?
| Flow Cytometry | 4 | 2011 | 1156 | 0.140 |
Why?
| Membrane Glycoproteins | 2 | 2018 | 474 | 0.140 |
Why?
| Neoplasm Grading | 2 | 2015 | 285 | 0.130 |
Why?
| Base Sequence | 6 | 2009 | 2142 | 0.130 |
Why?
| Cadherins | 2 | 2015 | 188 | 0.130 |
Why?
| Oxalates | 3 | 2011 | 10 | 0.120 |
Why?
| Cyclic AMP | 1 | 1996 | 237 | 0.120 |
Why?
| Transforming Growth Factor beta2 | 2 | 2014 | 35 | 0.120 |
Why?
| Recombination, Genetic | 2 | 2007 | 190 | 0.120 |
Why?
| Oncolytic Viruses | 1 | 2015 | 7 | 0.120 |
Why?
| Oncolytic Virotherapy | 1 | 2015 | 13 | 0.120 |
Why?
| Vesiculovirus | 1 | 2015 | 16 | 0.120 |
Why?
| Fluorodeoxyglucose F18 | 1 | 2015 | 129 | 0.120 |
Why?
| Down-Regulation | 2 | 2014 | 636 | 0.120 |
Why?
| Adenocarcinoma | 2 | 2019 | 898 | 0.110 |
Why?
| Receptors, Eicosanoid | 2 | 2005 | 2 | 0.110 |
Why?
| Endotoxins | 1 | 2015 | 220 | 0.110 |
Why?
| Metabolism | 1 | 2014 | 38 | 0.110 |
Why?
| Lipid Metabolism | 2 | 2015 | 497 | 0.110 |
Why?
| Cyclin-Dependent Kinase Inhibitor p21 | 2 | 2005 | 117 | 0.110 |
Why?
| Oxidation-Reduction | 2 | 2015 | 1033 | 0.110 |
Why?
| Liver | 3 | 2004 | 1839 | 0.110 |
Why?
| Random Allocation | 1 | 2014 | 346 | 0.110 |
Why?
| Proto-Oncogenes | 1 | 2013 | 29 | 0.100 |
Why?
| Litter Size | 1 | 1992 | 16 | 0.100 |
Why?
| Luciferases | 2 | 2003 | 148 | 0.100 |
Why?
| Real-Time Polymerase Chain Reaction | 1 | 2013 | 331 | 0.100 |
Why?
| Oligonucleotide Array Sequence Analysis | 2 | 2011 | 769 | 0.100 |
Why?
| Silymarin | 1 | 2014 | 199 | 0.100 |
Why?
| DNA Copy Number Variations | 1 | 2013 | 170 | 0.100 |
Why?
| Hydroxyproline | 1 | 2011 | 21 | 0.100 |
Why?
| Dietary Fats, Unsaturated | 1 | 2011 | 23 | 0.100 |
Why?
| Electrophoresis | 1 | 2011 | 30 | 0.100 |
Why?
| Genes, Retinoblastoma | 1 | 2011 | 8 | 0.090 |
Why?
| Xenograft Model Antitumor Assays | 1 | 2014 | 814 | 0.090 |
Why?
| Genes, p16 | 1 | 2011 | 19 | 0.090 |
Why?
| Fatty Acids, Unsaturated | 1 | 2011 | 97 | 0.090 |
Why?
| Nestin | 1 | 2011 | 19 | 0.090 |
Why?
| Microfluidic Analytical Techniques | 1 | 2011 | 73 | 0.090 |
Why?
| Ribonucleosides | 1 | 2010 | 6 | 0.090 |
Why?
| Chromatin Assembly and Disassembly | 1 | 2011 | 101 | 0.090 |
Why?
| Oxadiazoles | 1 | 2010 | 33 | 0.090 |
Why?
| Proto-Oncogene Proteins c-pim-1 | 1 | 2010 | 2 | 0.090 |
Why?
| S-Phase Kinase-Associated Proteins | 1 | 2010 | 20 | 0.090 |
Why?
| Gene Expression Regulation, Developmental | 1 | 2015 | 821 | 0.090 |
Why?
| Organ Specificity | 1 | 2011 | 296 | 0.090 |
Why?
| Disease Progression | 2 | 2015 | 2635 | 0.090 |
Why?
| Amino Acid Sequence | 3 | 2000 | 2058 | 0.090 |
Why?
| Cell Separation | 1 | 2011 | 316 | 0.090 |
Why?
| Aryl Hydrocarbon Receptor Nuclear Translocator | 1 | 2010 | 16 | 0.090 |
Why?
| Fatty Acids, Omega-3 | 1 | 2011 | 138 | 0.090 |
Why?
| Hydroxypyruvate Reductase | 2 | 2000 | 2 | 0.080 |
Why?
| Glucose | 1 | 2015 | 1003 | 0.080 |
Why?
| Endothelial Cells | 1 | 2015 | 749 | 0.080 |
Why?
| Expressed Sequence Tags | 2 | 2000 | 41 | 0.080 |
Why?
| Brain Neoplasms | 1 | 2019 | 1171 | 0.080 |
Why?
| Parathyroid Hormone-Related Protein | 4 | 1997 | 24 | 0.080 |
Why?
| YY1 Transcription Factor | 1 | 2009 | 28 | 0.080 |
Why?
| TNF-Related Apoptosis-Inducing Ligand | 3 | 2016 | 43 | 0.080 |
Why?
| DNA, Complementary | 2 | 2000 | 270 | 0.080 |
Why?
| Prostatic Secretory Proteins | 1 | 2009 | 4 | 0.080 |
Why?
| Physical Chromosome Mapping | 1 | 2009 | 17 | 0.080 |
Why?
| Chromosomes, Human, Pair 10 | 1 | 2009 | 18 | 0.080 |
Why?
| Genetic Predisposition to Disease | 5 | 2009 | 2282 | 0.080 |
Why?
| Sequence Homology, Amino Acid | 2 | 2000 | 372 | 0.080 |
Why?
| Hypoglycemic Agents | 2 | 2015 | 1220 | 0.080 |
Why?
| Risk Factors | 2 | 2021 | 9765 | 0.080 |
Why?
| Phosphatidylinositol 3-Kinases | 1 | 2010 | 359 | 0.080 |
Why?
| RNA-Binding Proteins | 3 | 2022 | 388 | 0.070 |
Why?
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2010 | 274 | 0.070 |
Why?
| Ataxins | 1 | 2007 | 3 | 0.070 |
Why?
| Ataxin-1 | 1 | 2007 | 4 | 0.070 |
Why?
| Integrin alpha6 | 1 | 2007 | 9 | 0.070 |
Why?
| Growth Hormone | 3 | 1992 | 96 | 0.070 |
Why?
| Alleles | 2 | 2008 | 845 | 0.070 |
Why?
| Rats | 4 | 2015 | 5500 | 0.070 |
Why?
| Gene Frequency | 1 | 2009 | 503 | 0.070 |
Why?
| Statistics, Nonparametric | 1 | 2008 | 422 | 0.070 |
Why?
| Chromosomes, Human, Pair 6 | 1 | 2007 | 51 | 0.070 |
Why?
| Response Elements | 2 | 2009 | 90 | 0.070 |
Why?
| Cell Movement | 1 | 2012 | 945 | 0.070 |
Why?
| Culture Media, Serum-Free | 2 | 2005 | 49 | 0.070 |
Why?
| Chi-Square Distribution | 1 | 2008 | 516 | 0.070 |
Why?
| Clone Cells | 1 | 2007 | 261 | 0.070 |
Why?
| Chromosome Deletion | 1 | 2007 | 104 | 0.070 |
Why?
| Japan | 1 | 2007 | 98 | 0.070 |
Why?
| Middle Aged | 9 | 2013 | 31155 | 0.070 |
Why?
| Hydroxyeicosatetraenoic Acids | 2 | 2005 | 42 | 0.070 |
Why?
| Receptor-Interacting Protein Serine-Threonine Kinases | 2 | 2016 | 14 | 0.070 |
Why?
| Reverse Transcriptase Polymerase Chain Reaction | 3 | 2010 | 958 | 0.070 |
Why?
| Carbohydrate Dehydrogenases | 1 | 2006 | 11 | 0.060 |
Why?
| Mutagenesis, Site-Directed | 1 | 2007 | 361 | 0.060 |
Why?
| RNA, Messenger | 5 | 2011 | 2708 | 0.060 |
Why?
| Dose-Response Relationship, Drug | 1 | 2010 | 2012 | 0.060 |
Why?
| Blotting, Western | 2 | 2006 | 1205 | 0.060 |
Why?
| Genetic Vectors | 1 | 2007 | 312 | 0.060 |
Why?
| DNA, Neoplasm | 2 | 2003 | 159 | 0.060 |
Why?
| Parainfluenza Virus 5 | 1 | 2005 | 1 | 0.060 |
Why?
| Prostatic Diseases | 1 | 2005 | 5 | 0.060 |
Why?
| Arachidonic Acids | 1 | 2005 | 59 | 0.060 |
Why?
| Viral Structural Proteins | 1 | 2005 | 12 | 0.060 |
Why?
| Vesicular stomatitis Indiana virus | 1 | 2004 | 13 | 0.060 |
Why?
| Viral Matrix Proteins | 1 | 2004 | 26 | 0.060 |
Why?
| Tolonium Chloride | 1 | 2004 | 3 | 0.060 |
Why?
| ADP Ribose Transferases | 1 | 2004 | 8 | 0.060 |
Why?
| Glycolates | 1 | 2004 | 3 | 0.060 |
Why?
| DNA Mutational Analysis | 2 | 2009 | 387 | 0.060 |
Why?
| Glyoxylates | 1 | 2004 | 9 | 0.060 |
Why?
| Coloring Agents | 1 | 2004 | 77 | 0.060 |
Why?
| Reference Values | 1 | 2006 | 793 | 0.060 |
Why?
| Calcium Channel Agonists | 1 | 2004 | 12 | 0.060 |
Why?
| Interferon Type I | 1 | 2005 | 139 | 0.060 |
Why?
| Steroid Hydroxylases | 1 | 2004 | 22 | 0.060 |
Why?
| Lung | 2 | 2015 | 3931 | 0.060 |
Why?
| Adult | 6 | 2013 | 35577 | 0.060 |
Why?
| Predictive Value of Tests | 2 | 2013 | 1952 | 0.050 |
Why?
| Ergocalciferols | 1 | 2003 | 11 | 0.050 |
Why?
| Microscopy, Fluorescence | 1 | 2005 | 400 | 0.050 |
Why?
| MicroRNAs | 1 | 2010 | 678 | 0.050 |
Why?
| Radiation-Sensitizing Agents | 1 | 2003 | 40 | 0.050 |
Why?
| beta-Galactosidase | 1 | 2003 | 77 | 0.050 |
Why?
| Palpation | 1 | 2003 | 11 | 0.050 |
Why?
| Analysis of Variance | 2 | 2003 | 1288 | 0.050 |
Why?
| Sequence Analysis, DNA | 2 | 2003 | 779 | 0.050 |
Why?
| Cytochrome P-450 Enzyme System | 1 | 2004 | 151 | 0.050 |
Why?
| Trinucleotide Repeats | 1 | 2003 | 25 | 0.050 |
Why?
| Transcription, Genetic | 1 | 2009 | 1418 | 0.050 |
Why?
| Gene Amplification | 1 | 2003 | 105 | 0.050 |
Why?
| Cell Culture Techniques | 1 | 2005 | 345 | 0.050 |
Why?
| Phosphoproteins | 1 | 2005 | 332 | 0.050 |
Why?
| Reproducibility of Results | 2 | 2011 | 3083 | 0.050 |
Why?
| G2 Phase | 1 | 2002 | 36 | 0.050 |
Why?
| Up-Regulation | 2 | 2004 | 840 | 0.050 |
Why?
| Viral Proteins | 1 | 2005 | 328 | 0.050 |
Why?
| G1 Phase | 1 | 2002 | 70 | 0.050 |
Why?
| Cyclin-Dependent Kinase Inhibitor p27 | 1 | 2002 | 73 | 0.050 |
Why?
| Radioimmunoassay | 2 | 1992 | 175 | 0.050 |
Why?
| Peptide Elongation Factors | 1 | 2022 | 15 | 0.050 |
Why?
| Cloning, Molecular | 1 | 2003 | 524 | 0.050 |
Why?
| Genes, Tumor Suppressor | 1 | 2002 | 86 | 0.050 |
Why?
| Transforming Growth Factor beta | 1 | 2005 | 457 | 0.050 |
Why?
| Transcription Factors | 1 | 2010 | 1651 | 0.050 |
Why?
| Haplotypes | 1 | 2003 | 475 | 0.050 |
Why?
| Embryo, Mammalian | 1 | 2002 | 226 | 0.050 |
Why?
| Aged | 6 | 2013 | 22104 | 0.050 |
Why?
| In Vitro Techniques | 1 | 2003 | 1085 | 0.050 |
Why?
| Vitamin D3 24-Hydroxylase | 2 | 2015 | 15 | 0.040 |
Why?
| Founder Effect | 1 | 2000 | 12 | 0.040 |
Why?
| Kinetics | 2 | 1996 | 1642 | 0.040 |
Why?
| MAP Kinase Signaling System | 1 | 2002 | 312 | 0.040 |
Why?
| Multienzyme Complexes | 1 | 2000 | 68 | 0.040 |
Why?
| Codon, Nonsense | 1 | 2000 | 39 | 0.040 |
Why?
| Glyceric Acids | 1 | 2000 | 6 | 0.040 |
Why?
| Chromosomes, Human, Pair 9 | 1 | 2000 | 39 | 0.040 |
Why?
| Mixed Function Oxygenases | 1 | 2000 | 41 | 0.040 |
Why?
| Polymorphism, Single-Stranded Conformational | 1 | 1999 | 28 | 0.040 |
Why?
| Consensus Sequence | 1 | 1999 | 72 | 0.040 |
Why?
| Gene Knockdown Techniques | 2 | 2011 | 315 | 0.040 |
Why?
| Microsatellite Repeats | 1 | 2000 | 164 | 0.040 |
Why?
| Chemoprevention | 1 | 2000 | 91 | 0.040 |
Why?
| Trans-Activators | 1 | 2022 | 388 | 0.040 |
Why?
| Time Factors | 4 | 2009 | 6556 | 0.040 |
Why?
| Codon | 1 | 1999 | 86 | 0.040 |
Why?
| COS Cells | 1 | 1999 | 185 | 0.040 |
Why?
| Genes | 1 | 1999 | 226 | 0.040 |
Why?
| Tissue Distribution | 1 | 2000 | 315 | 0.040 |
Why?
| Parenchymal Tissue | 1 | 2019 | 6 | 0.040 |
Why?
| Green Fluorescent Proteins | 2 | 2015 | 385 | 0.040 |
Why?
| Cell Death | 2 | 2015 | 354 | 0.040 |
Why?
| Transcriptional Regulator ERG | 1 | 2019 | 19 | 0.040 |
Why?
| Sequence Alignment | 1 | 1999 | 332 | 0.040 |
Why?
| Sweden | 2 | 2009 | 93 | 0.040 |
Why?
| Nicotinamide Phosphoribosyltransferase | 1 | 2018 | 7 | 0.040 |
Why?
| Transaminases | 2 | 2011 | 23 | 0.040 |
Why?
| Phenotype | 1 | 2007 | 3076 | 0.040 |
Why?
| Exons | 1 | 1999 | 342 | 0.040 |
Why?
| Species Specificity | 1 | 1999 | 575 | 0.040 |
Why?
| Serine Endopeptidases | 1 | 2019 | 118 | 0.040 |
Why?
| Acrylamides | 1 | 2018 | 58 | 0.040 |
Why?
| Cellular Reprogramming | 1 | 2018 | 95 | 0.040 |
Why?
| Tretinoin | 1 | 2018 | 130 | 0.030 |
Why?
| Recombinant Proteins | 2 | 2015 | 1304 | 0.030 |
Why?
| Mitochondria | 2 | 2018 | 877 | 0.030 |
Why?
| Piperidines | 1 | 2018 | 199 | 0.030 |
Why?
| Prevalence | 1 | 2003 | 2564 | 0.030 |
Why?
| Receptors, Death Domain | 1 | 2016 | 3 | 0.030 |
Why?
| Autophagy-Related Protein 5 | 1 | 2016 | 7 | 0.030 |
Why?
| Autophagosomes | 1 | 2016 | 19 | 0.030 |
Why?
| Biomarkers | 1 | 2007 | 3973 | 0.030 |
Why?
| Protein Kinases | 1 | 2018 | 318 | 0.030 |
Why?
| Culture Media | 1 | 1996 | 162 | 0.030 |
Why?
| Epidermal Growth Factor | 1 | 1996 | 171 | 0.030 |
Why?
| Cell Survival | 2 | 2011 | 1086 | 0.030 |
Why?
| Pregnancy | 3 | 1992 | 6402 | 0.030 |
Why?
| Fatty Acids | 1 | 2018 | 427 | 0.030 |
Why?
| Epithelium | 1 | 1996 | 311 | 0.030 |
Why?
| Genes, Viral | 1 | 2015 | 82 | 0.030 |
Why?
| Heterografts | 1 | 2015 | 131 | 0.030 |
Why?
| Disease Models, Animal | 1 | 2005 | 4063 | 0.030 |
Why?
| STAT1 Transcription Factor | 1 | 2015 | 70 | 0.030 |
Why?
| Poly(ADP-ribose) Polymerases | 2 | 2005 | 94 | 0.030 |
Why?
| Lipids | 1 | 2018 | 625 | 0.030 |
Why?
| Pertussis Toxin | 2 | 2005 | 26 | 0.030 |
Why?
| Caspases | 2 | 2005 | 245 | 0.030 |
Why?
| Positron-Emission Tomography | 1 | 2015 | 288 | 0.030 |
Why?
| Case-Control Studies | 3 | 2009 | 3381 | 0.030 |
Why?
| Female | 5 | 2006 | 68777 | 0.030 |
Why?
| Placental Lactogen | 1 | 1992 | 24 | 0.030 |
Why?
| Sheep | 1 | 2015 | 837 | 0.030 |
Why?
| Phosphorylation | 2 | 2010 | 1713 | 0.020 |
Why?
| Blotting, Northern | 1 | 1992 | 200 | 0.020 |
Why?
| Models, Biological | 1 | 2000 | 1722 | 0.020 |
Why?
| Microsomes, Liver | 1 | 1992 | 87 | 0.020 |
Why?
| Transcriptome | 1 | 2018 | 887 | 0.020 |
Why?
| Nephrocalcinosis | 1 | 2011 | 3 | 0.020 |
Why?
| Immunohistochemistry | 1 | 1996 | 1698 | 0.020 |
Why?
| Protein Binding | 2 | 2010 | 2121 | 0.020 |
Why?
| Binding, Competitive | 1 | 1992 | 206 | 0.020 |
Why?
| Animal Feed | 1 | 2011 | 50 | 0.020 |
Why?
| Orchiectomy | 1 | 2011 | 67 | 0.020 |
Why?
| Fatty Acids, Omega-6 | 1 | 2011 | 47 | 0.020 |
Why?
| Fatty Acid Desaturases | 1 | 2011 | 32 | 0.020 |
Why?
| Gene Knockout Techniques | 1 | 2011 | 109 | 0.020 |
Why?
| Transplantation, Heterologous | 1 | 2011 | 192 | 0.020 |
Why?
| Homozygote | 1 | 2011 | 193 | 0.020 |
Why?
| Sensitivity and Specificity | 2 | 2009 | 1838 | 0.020 |
Why?
| Neoplasm Transplantation | 1 | 2011 | 257 | 0.020 |
Why?
| Proteolysis | 1 | 2011 | 166 | 0.020 |
Why?
| Proteasome Endopeptidase Complex | 1 | 2011 | 148 | 0.020 |
Why?
| Spheroids, Cellular | 1 | 2011 | 77 | 0.020 |
Why?
| Peptide Fragments | 1 | 1995 | 692 | 0.020 |
Why?
| Apc3 Subunit, Anaphase-Promoting Complex-Cyclosome | 1 | 2010 | 1 | 0.020 |
Why?
| Rabbits | 1 | 1992 | 778 | 0.020 |
Why?
| Bronchopulmonary Dysplasia | 1 | 2015 | 378 | 0.020 |
Why?
| Antioxidants | 1 | 2014 | 559 | 0.020 |
Why?
| S Phase | 1 | 2010 | 75 | 0.020 |
Why?
| Odds Ratio | 1 | 2013 | 1023 | 0.020 |
Why?
| Enhancer of Zeste Homolog 2 Protein | 1 | 2010 | 41 | 0.020 |
Why?
| Cytokines | 1 | 2018 | 2017 | 0.020 |
Why?
| Ubiquitination | 1 | 2010 | 98 | 0.020 |
Why?
| Electrophoresis, Polyacrylamide Gel | 1 | 2010 | 330 | 0.020 |
Why?
| Rats, Sprague-Dawley | 1 | 2015 | 2406 | 0.020 |
Why?
| Neovascularization, Pathologic | 1 | 2011 | 297 | 0.020 |
Why?
| Neoplasm Staging | 1 | 2013 | 1295 | 0.020 |
Why?
| Pulmonary Artery | 1 | 2015 | 1096 | 0.020 |
Why?
| Polycomb Repressive Complex 2 | 1 | 2010 | 63 | 0.020 |
Why?
| HEK293 Cells | 1 | 2011 | 697 | 0.020 |
Why?
| HeLa Cells | 1 | 2010 | 608 | 0.020 |
Why?
| Antigens, CD | 1 | 2010 | 489 | 0.020 |
Why?
| Computer Simulation | 1 | 2011 | 943 | 0.020 |
Why?
| Enzyme Activation | 1 | 2009 | 811 | 0.020 |
Why?
| Mice, Transgenic | 1 | 2011 | 2119 | 0.020 |
Why?
| Placenta | 1 | 1992 | 723 | 0.020 |
Why?
| Peroxisome Proliferator-Activated Receptors | 1 | 2005 | 15 | 0.020 |
Why?
| Prostaglandin D2 | 1 | 2005 | 22 | 0.020 |
Why?
| Poly (ADP-Ribose) Polymerase-1 | 1 | 2005 | 42 | 0.020 |
Why?
| Fas-Associated Death Domain Protein | 1 | 2005 | 9 | 0.010 |
Why?
| Anilides | 1 | 2005 | 73 | 0.010 |
Why?
| Multivariate Analysis | 1 | 2009 | 1502 | 0.010 |
Why?
| ADP-Ribosylation Factors | 1 | 2005 | 18 | 0.010 |
Why?
| Caspase 8 | 1 | 2005 | 48 | 0.010 |
Why?
| DNA Fragmentation | 1 | 2004 | 44 | 0.010 |
Why?
| Retinoblastoma Protein | 1 | 2005 | 54 | 0.010 |
Why?
| Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2005 | 69 | 0.010 |
Why?
| Prognosis | 1 | 2013 | 3794 | 0.010 |
Why?
| Peroxisomes | 1 | 2004 | 12 | 0.010 |
Why?
| Caspase 3 | 1 | 2005 | 245 | 0.010 |
Why?
| Mitosis | 1 | 2005 | 180 | 0.010 |
Why?
| L-Lactate Dehydrogenase | 1 | 2004 | 119 | 0.010 |
Why?
| Microscopy, Electron | 1 | 2005 | 426 | 0.010 |
Why?
| PPAR gamma | 1 | 2005 | 183 | 0.010 |
Why?
| Apoptosis Regulatory Proteins | 1 | 2005 | 182 | 0.010 |
Why?
| Adenoviridae | 1 | 2005 | 192 | 0.010 |
Why?
| Diet | 1 | 2011 | 1213 | 0.010 |
Why?
| Models, Molecular | 1 | 2009 | 1492 | 0.010 |
Why?
| Radiation, Ionizing | 1 | 2003 | 76 | 0.010 |
Why?
| Phagocytosis | 1 | 2005 | 362 | 0.010 |
Why?
| Stimulation, Chemical | 1 | 2002 | 63 | 0.010 |
Why?
| Carcinoma | 1 | 2005 | 217 | 0.010 |
Why?
| DNA Primers | 1 | 2004 | 510 | 0.010 |
Why?
| Benzoquinones | 1 | 2002 | 48 | 0.010 |
Why?
| Protein Structure, Tertiary | 1 | 2005 | 840 | 0.010 |
Why?
| Mitogen-Activated Protein Kinase 3 | 1 | 2002 | 151 | 0.010 |
Why?
| Binding Sites | 1 | 2005 | 1252 | 0.010 |
Why?
| Cattle | 1 | 2005 | 976 | 0.010 |
Why?
| GTP-Binding Proteins | 1 | 2002 | 157 | 0.010 |
Why?
| Adaptor Proteins, Signal Transducing | 1 | 2005 | 399 | 0.010 |
Why?
| Virus Replication | 1 | 2004 | 451 | 0.010 |
Why?
| Mitogen-Activated Protein Kinase 1 | 1 | 2002 | 184 | 0.010 |
Why?
| Mice, Inbred BALB C | 1 | 2004 | 1245 | 0.010 |
Why?
| Intracellular Signaling Peptides and Proteins | 1 | 2005 | 442 | 0.010 |
Why?
| Probability | 1 | 2002 | 306 | 0.010 |
Why?
| Retrospective Studies | 1 | 2019 | 14518 | 0.010 |
Why?
| Mitogen-Activated Protein Kinases | 1 | 2002 | 312 | 0.010 |
Why?
| Registries | 1 | 2009 | 1896 | 0.010 |
Why?
| Tumor Suppressor Protein p53 | 1 | 2005 | 511 | 0.010 |
Why?
| Inflammation | 1 | 2011 | 2736 | 0.010 |
Why?
| Indoles | 1 | 2002 | 387 | 0.010 |
Why?
| Tumor Necrosis Factor-alpha | 1 | 2005 | 1198 | 0.010 |
Why?
| Genetic Variation | 1 | 2004 | 937 | 0.010 |
Why?
| Proto-Oncogene Proteins | 1 | 2002 | 638 | 0.010 |
Why?
| Cell Count | 1 | 1997 | 314 | 0.010 |
Why?
| Phorbol Esters | 1 | 1995 | 15 | 0.010 |
Why?
| Teriparatide | 1 | 1995 | 6 | 0.010 |
Why?
| Colforsin | 1 | 1995 | 50 | 0.010 |
Why?
| Second Messenger Systems | 1 | 1995 | 33 | 0.010 |
Why?
| Osteosarcoma | 1 | 1995 | 72 | 0.010 |
Why?
| Brain | 1 | 2004 | 2679 | 0.010 |
Why?
| Cohort Studies | 1 | 2002 | 5420 | 0.010 |
Why?
| Aged, 80 and over | 1 | 2002 | 7086 | 0.010 |
Why?
| Prospective Studies | 1 | 2002 | 7133 | 0.010 |
Why?
|
|
Cramer's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|